Two substandard drugs have been suspended from circulation.
The Drug Administration has just announced the suspension of the circulation of two types of capsule medications, Euroseafox and Cefaclor.
The Hanoi Department of Health has just issued a document to public and private medical facilities under its jurisdiction, requesting the suspension of the circulation of two types of capsule medications, Euroseafox and Cefaclor, that do not meet quality standards.
Previously, the Hanoi Department of Health received a document from the Drug Administration of Vietnam (Ministry of Health) announcing the suspension of the circulation of the two aforementioned drugs due to failure to meet quality standards regarding dissolution rate.
Euroseafox capsules, registration number: VN-12288-11, batch number: 03, manufacturing date: 09/06/2013, expiry date: 09/06/2016, are manufactured by a company in Bangladesh and imported by the Hanoi branch of Vimedimex Pharmaceutical Joint Stock Company. This sample was taken from Viet Anh Pharmaceutical Co., Ltd. (counter 212, 2nd floor, 24T1 building (Hapulico) – No. 1 Nguyen Huy Tuong, Thanh Xuan, Hanoi). The Cefaclor capsule has registration number: VD-10807-10, batch number: 0112, manufacturing date: 29/11/2012, expiry date: 29/11/2015. This drug is manufactured by Mebiphar Pharmaceutical and Medical Biological Co., Ltd. This sample was taken from Trang Vinh Pharmaceutical Joint Stock Company (counter 512, 5th floor, 24T1 building (Hapulico) – No. 1 Nguyen Huy Tuong, Thanh Xuan, Hanoi).
According to Vov
